Example of Biomarker Research format
Recent searches

Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format Example of Biomarker Research format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Biomarker Research — Template for authors

Publisher: Springer
Categories Rank Trend in last 3 yrs
Clinical Biochemistry #17 of 113 down down by 10 ranks
Biochemistry (medical) #9 of 54 down down by 5 ranks
Molecular Medicine #37 of 167 down down by 15 ranks
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 161 Published Papers | 1241 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 03/07/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

Springer

Quality:  
High
CiteRatio: 5.0
SJR: 0.649
SNIP: 1.155
open access Open Access
recommended Recommended

Springer

Quality:  
High
CiteRatio: 11.4
SJR: 2.182
SNIP: 1.902
open access Open Access
recommended Recommended

Elsevier

Quality:  
High
CiteRatio: 20.0
SJR: 3.492
SNIP: 2.719
open access Open Access
recommended Recommended

Taylor and Francis

Quality:  
High
CiteRatio: 9.0
SJR: 1.964
SNIP: 1.376

Journal Performance & Insights

CiteRatio

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

A measure of average citations received per peer-reviewed paper published in the journal.

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

7.7

17% from 2019

CiteRatio for Biomarker Research from 2016 - 2020
Year Value
2020 7.7
2019 6.6
2018 3.8
2017 8.6
graph view Graph view
table view Table view

1.633

26% from 2019

SJR for Biomarker Research from 2018 - 2020
Year Value
2020 1.633
2019 1.298
2018 1.182
graph view Graph view
table view Table view

1.452

36% from 2019

SNIP for Biomarker Research from 2017 - 2020
Year Value
2020 1.452
2019 1.068
2018 0.974
2017 1.101
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has increased by 17% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

insights Insights

  • SJR of this journal has increased by 26% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 36% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Biomarker Research

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Springer

Biomarker Research

Approved by publishing and review experts on SciSpace, this template is built as per for Biomarker Research formatting guidelines as mentioned in Springer author instructions. The current version was created on and has been used by 785 authors to write and format their manuscripts to this journal.

i
Last updated on
03 Jul 2020
i
ISSN
1606-8610
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
White faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Citation Type
Numbered
[25]
i
Bibliography Example
Blonder, G.E., Tinkham, M., Klapwijk, T.M.: Transition from metallic to tunneling regimes in superconducting microconstrictions: Excess current, charge imbalance, and supercurrent conversion. Phys. Rev. B 25(7), 4515–4532 (1982)

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.1186/2050-7771-2-1
Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases
Jiyeon Yang1, Lixiao Zhang1, Caijia Yu1, Xiaofeng Yang1, Hong Wang1
07 Jan 2014 - Biomarker research

Abstract:

Monocytes express various receptors, which monitor and sense environmental changes. Monocytes are highly plastic and heterogeneous, and change their functional phenotype in response to environmental stimulation. Evidence from murine and human studies has suggested that monocytosis can be an indicator of various inflammatory d... Monocytes express various receptors, which monitor and sense environmental changes. Monocytes are highly plastic and heterogeneous, and change their functional phenotype in response to environmental stimulation. Evidence from murine and human studies has suggested that monocytosis can be an indicator of various inflammatory diseases. Monocytes can differentiate into inflammatory or anti-inflammatory subsets. Upon tissue damage or infection, monocytes are rapidly recruited to the tissue, where they can differentiate into tissue macrophages or dendritic cells. Given the rapid progress in monocyte research from broad spectrum of inflammatory diseases, there is a need to summarize our knowledge in monocyte heterogeneity and its impact in human disease. In this review, we describe the current understanding of heterogeneity of human and murine monocytes, the function of distinct subsets of monocytes, and a potential mechanism for monocyte differentiation. We emphasize that inflammatory monocyte subsets are valuable biomarkers for inflammatory diseases, including cardiovascular diseases. read more read less

Topics:

Monocyte differentiation (69%)69% related to the paper, Monocyte (63%)63% related to the paper, Monocytosis (58%)58% related to the paper
View PDF
816 Citations
open accessOpen access Journal Article DOI: 10.1186/S40364-020-00228-X
Roles of IFN-γ in tumor progression and regression: a review.
Dragica Jorgovanovic1, Mengjia Song2, Liping Wang1, Yi Zhang
29 Sep 2020 - Biomarker research

Abstract:

Interferon-γ (IFN-γ) plays a key role in activation of cellular immunity and subsequently, stimulation of antitumor immune-response. Based on its cytostatic, pro-apoptotic and antiproliferative functions, IFN-γ is considered potentially useful for adjuvant immunotherapy for different types of cancer. Moreover, it IFN-γ may in... Interferon-γ (IFN-γ) plays a key role in activation of cellular immunity and subsequently, stimulation of antitumor immune-response. Based on its cytostatic, pro-apoptotic and antiproliferative functions, IFN-γ is considered potentially useful for adjuvant immunotherapy for different types of cancer. Moreover, it IFN-γ may inhibit angiogenesis in tumor tissue, induce regulatory T-cell apoptosis, and/or stimulate the activity of M1 proinflammatory macrophages to overcome tumor progression. However, the current understanding of the roles of IFN-γ in the tumor microenvironment (TME) may be misleading in terms of its clinical application. Some researchers believe it has anti-tumorigenic properties, while others suggest that it contributes to tumor growth and progression. In our recent work, we have shown that concentration of IFN-γ in the TME determines its function. Further, it was reported that tumors treated with low-dose IFN-γ acquired metastatic properties while those infused with high dose led to tumor regression. Pro-tumorigenic role may be described through IFN-γ signaling insensitivity, downregulation of major histocompatibility complexes, upregulation of indoleamine 2,3-dioxygenase, and checkpoint inhibitors such as programmed cell death ligand 1. Significant research efforts are required to decipher IFN-γ-dependent pro- and anti-tumorigenic effects. This review discusses the current knowledge concerning the roles of IFN-γ in the TME as a part of the complex immune response to cancer and highlights the importance of identifying IFN-γ responsive patients to improve their sensitivity to immuno-therapies. read more read less

Topics:

Tumor progression (62%)62% related to the paper, Tumor microenvironment (57%)57% related to the paper, Cellular immunity (54%)54% related to the paper, Proinflammatory cytokine (51%)51% related to the paper, Immunotherapy (50%)50% related to the paper
View PDF
360 Citations
open accessOpen access Journal Article DOI: 10.1186/S40364-017-0102-Y
Engineering CAR-T cells.
Cheng Zhang1, Jun Liu1, Jiang F. Zhong2, Xi Zhang1
24 Jun 2017 - Biomarker research

Abstract:

Chimeric antigen receptor redirected T cells (CAR-T cells) have achieved inspiring outcomes in patients with B cell malignancies, and are now being investigated in other hematologic malignancies and solid tumors. CAR-T cells are generated by the T cells from patients’ or donors’ blood. After the T cells are expanded and genet... Chimeric antigen receptor redirected T cells (CAR-T cells) have achieved inspiring outcomes in patients with B cell malignancies, and are now being investigated in other hematologic malignancies and solid tumors. CAR-T cells are generated by the T cells from patients’ or donors’ blood. After the T cells are expanded and genetically modified, they are reinfused into the patients. However, many challenges still need to be resolved in order for this technology to gain widespread adoption. In this review, we first discuss the structure and evolution of chimeric antigen receptors. We then report on the tools used for production of CAR-T cells. Finally, we address the challenges posed by CAR-T cells. read more read less

Topics:

Chimeric antigen receptor (59%)59% related to the paper, Adoptive cell transfer (58%)58% related to the paper, B cell (58%)58% related to the paper
View PDF
317 Citations
open accessOpen access Journal Article DOI: 10.1186/S40364-017-0097-4
Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives
Tsung Rong Kuo1, Chih Hwa Chen1, Chih Hwa Chen2
18 May 2017 - Biomarker research

Abstract:

Bone biomarkers included formation, resorption and regulator are released during the bone remodeling processes. These bone biomarkers have attracted much attention in the clinical assessment of osteoporosis treatment in the past decade. Combination with the measurement of bone mineral density, the clinical applications of bon... Bone biomarkers included formation, resorption and regulator are released during the bone remodeling processes. These bone biomarkers have attracted much attention in the clinical assessment of osteoporosis treatment in the past decade. Combination with the measurement of bone mineral density, the clinical applications of bone biomarkers have provided comprehensive information for diagnosis of osteoporosis. However, the analytical approaches of the bone biomarkers are still the challenge for further clinical trials. In this mini-review, we have introduced the functions of bone biomarkers and then recently developed techniques for bone biomarker measurements have been systematically integrated to discuss the possibility for osteoporosis assessment in the early stage. read more read less

Topics:

Bone remodeling (60%)60% related to the paper, Osteoporosis (58%)58% related to the paper, Bone mineral (54%)54% related to the paper, Bone resorption (53%)53% related to the paper
View PDF
274 Citations
open accessOpen access Journal Article DOI: 10.1186/S40364-018-0122-2
Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential.
Lu Gan1, Ya'nan Yang1, Qian Li1, Yi Feng1, Tianshu Liu1, Weijian Guo1
09 Mar 2018 - Biomarker research

Abstract:

Enhancer of zeste homolog 2 (EZH2), a histone methyltransferase and a catalytic component of PRC2, catalyzes tri-methylation of histone H3 at Lys 27 (H3K27me3) to regulate gene expression through epigenetic machinery. EZH2 also functions both as a transcriptional suppressor and a transcriptional co-activator, depending on H3K... Enhancer of zeste homolog 2 (EZH2), a histone methyltransferase and a catalytic component of PRC2, catalyzes tri-methylation of histone H3 at Lys 27 (H3K27me3) to regulate gene expression through epigenetic machinery. EZH2 also functions both as a transcriptional suppressor and a transcriptional co-activator, depending on H3K27me3 or not and on the different cellular contexts. Unsurprisingly, numerous studies have highlighted the role of EZH2 in cancer development and progression. Through modulating critical gene expression, EZH2 promotes cell survival, proliferation, epithelial to mesenchymal, invasion, and drug resistance of cancer cells. The tumor suppressive effects of EZH2 are also identified. What is more, EZH2 has decisive roles in immune cells (for example, T cells, NK cells, dendritic cells and macrophages), which are essential components in tumor microenvironment. In this review, we aim to discuss the molecular functions of EZH2, highlight recent findings regarding the physiological functions and related regulation of EZH2 in cancer pathogenesis. Furthermore, we summarized and updated the emerging roles of EZH2 in tumor immunity, and current pre-clinical and clinical trials of EZH2 inhibitors in cancer therapy. read more read less

Topics:

Histone methyltransferase (58%)58% related to the paper, EZH2 (57%)57% related to the paper, Tumor microenvironment (56%)56% related to the paper, Epigenetics (55%)55% related to the paper, PRC2 (55%)55% related to the paper
View PDF
243 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Biomarker Research.

It automatically formats your research paper to Springer formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Biomarker Research in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Biomarker Research guidelines and auto format it.

2. Do you follow the Biomarker Research guidelines?

Yes, the template is compliant with the Biomarker Research guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Biomarker Research?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Biomarker Research citation style.

4. Can I use the Biomarker Research templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Biomarker Research.

5. Can I use a manuscript in Biomarker Research that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Biomarker Research that you can download at the end.

6. How long does it usually take you to format my papers in Biomarker Research?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Biomarker Research.

7. Where can I find the template for the Biomarker Research?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Biomarker Research's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Biomarker Research's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Biomarker Research an online tool or is there a desktop version?

SciSpace's Biomarker Research is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Biomarker Research?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Biomarker Research?”

11. What is the output that I would get after using Biomarker Research?

After writing your paper autoformatting in Biomarker Research, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Biomarker Research's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Biomarker Research?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Biomarker Research. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Biomarker Research?

The 5 most common citation types in order of usage for Biomarker Research are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Biomarker Research?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Biomarker Research's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Biomarker Research in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Biomarker Research Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Biomarker Research formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template